Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-10-18

Clinical Trial Update: STRETTA ,Radio Frequency Ablation (RFA) v/s Sham Therapy for the Treatment of Refractory GERD [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the STRETTA radiofrequency ablation procedure versus sham therapy for refractory gastroesophageal reflux disease, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • STRETTA

Snippet

Sponsor: Asian Institute of Gastroenterology, India | Conditions: GERD | Phase 3 | Status: UNKNOWN